ID   AIMP1_HUMAN             Reviewed;         312 AA.
AC   Q12904; B3KTR2; B4E1S7; Q6FG28; Q96CQ9;
DT   18-OCT-2001, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2006, sequence version 2.
DT   18-JUN-2025, entry version 217.
DE   RecName: Full=Aminoacyl tRNA synthase complex-interacting multifunctional protein 1;
DE   AltName: Full=Multisynthase complex auxiliary component p43;
DE   Contains:
DE     RecName: Full=Endothelial monocyte-activating polypeptide 2;
DE              Short=EMAP-2;
DE     AltName: Full=Endothelial monocyte-activating polypeptide II;
DE              Short=EMAP-II;
DE     AltName: Full=Small inducible cytokine subfamily E member 1;
GN   Name=AIMP1; Synonyms=EMAP2, SCYE1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ALA-79.
RX   PubMed=7929199; DOI=10.1016/s0021-9258(17)31505-3;
RA   Kao J., Houck K., Fan Y., Haehnel I., Libutti S.K., Kayton M.L.,
RA   Grikscheit T., Chabot J., Nowygrod R., Greenberg S., Kuang W.J.,
RA   Leung D.W., Hayward J.R., Kisiel W., Heath M., Brett J., Stern D.M.;
RT   "Characterization of a novel tumor-derived cytokine. Endothelial-monocyte
RT   activating polypeptide II.";
RL   J. Biol. Chem. 269:25106-25119(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S., Neubert P.,
RA   Kstrang K., Schatten R., Shen B., Henze S., Mar W., Korn B., Zuo D., Hu Y.,
RA   LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 1-9, ALTERNATIVE SPLICING, IDENTIFICATION IN THE MSC
RP   COMPLEX, INTERACTION WITH TARS3, CLEAVAGE OF INITIATOR METHIONINE,
RP   ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS SPECTROMETRY (ISOFORMS 1
RP   AND 2).
RX   PubMed=24312579; DOI=10.1371/journal.pone.0081734;
RA   Kim K., Park S.J., Na S., Kim J.S., Choi H., Kim Y.K., Paek E., Lee C.;
RT   "Reinvestigation of aminoacyl-tRNA synthetase core complex by affinity
RT   purification-mass spectrometry reveals TARSL2 as a potential member of the
RT   complex.";
RL   PLoS ONE 8:E81734-E81734(2013).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH RARS1.
RX   PubMed=10358004; DOI=10.1074/jbc.274.24.16673;
RA   Park S.G., Jung K.H., Lee J.S., Jo Y.J., Motegi H., Kim S., Shiba K.;
RT   "Precursor of pro-apoptotic cytokine modulates aminoacylation activity of
RT   tRNA synthetase.";
RL   J. Biol. Chem. 274:16673-16676(1999).
RN   [7]
RP   SUBCELLULAR LOCATION, AND CLEAVAGE.
RX   PubMed=10850427;
RA   Barnett G., Jakobsen A.-M., Tas M., Rice K., Carmichael J., Murray J.C.;
RT   "Prostate adenocarcinoma cells release the novel proinflammatory
RT   polypeptide EMAP-II in response to stress.";
RL   Cancer Res. 60:2850-2857(2000).
RN   [8]
RP   FUNCTION, SUBUNIT, AND CLEAVAGE.
RX   PubMed=11306575; DOI=10.1074/jbc.m100489200;
RA   Shalak V., Kaminska M., Mitnacht-Kraus R., Vandenabeele P., Clauss M.,
RA   Mirande M.;
RT   "The EMAPII cytokine is released from the mammalian multisynthetase complex
RT   after cleavage of its p43/proEMAPII component.";
RL   J. Biol. Chem. 276:23769-23776(2001).
RN   [9]
RP   FUNCTION.
RX   PubMed=12237313; DOI=10.1074/jbc.m207934200;
RA   Park S.G., Kang Y.-S., Ahn Y.H., Lee S.H., Kim K.-R., Kim K.-W., Koh G.Y.,
RA   Ko Y.-G., Kim S.;
RT   "Dose-dependent biphasic activity of tRNA synthetase-associating factor,
RT   p43, in angiogenesis.";
RL   J. Biol. Chem. 277:45243-45248(2002).
RN   [10]
RP   FUNCTION.
RX   PubMed=11818442;
RA   Park H., Park S.G., Lee J.-W., Kim T., Kim G., Ko Y.-G., Kim S.;
RT   "Monocyte cell adhesion induced by a human aminoacyl-tRNA synthetase-
RT   associated factor, p43: identification of the related adhesion molecules
RT   and signal pathways.";
RL   J. Leukoc. Biol. 71:223-230(2002).
RN   [11]
RP   SUBCELLULAR LOCATION.
RX   PubMed=14500886; DOI=10.1110/ps.03147903;
RA   Wolfe C.L., Warrington J.A., Davis S., Green S., Norcum M.T.;
RT   "Isolation and characterization of human nuclear and cytosolic
RT   multisynthetase complexes and the intracellular distribution of
RT   p43/EMAPII.";
RL   Protein Sci. 12:2282-2290(2003).
RN   [12]
RP   REGIONS INVOLVED IN FIBROBLAST PROLIFERATION; ENDOTHELIAL CELL DEATH AND
RP   ENDOTHELIAL MIGRATION.
RX   PubMed=16472771; DOI=10.1016/j.bbrc.2006.01.117;
RA   Han J.M., Park S.G., Lee Y., Kim S.;
RT   "Structural separation of different extracellular activities in aminoacyl-
RT   tRNA synthetase-interacting multi-functional protein, p43/AIMP1.";
RL   Biochem. Biophys. Res. Commun. 342:113-118(2006).
RN   [13]
RP   INTERACTION WITH RARS1.
RX   PubMed=17443684; DOI=10.1002/jcp.21083;
RA   Bottoni A., Vignali C., Piccin D., Tagliati F., Luchin A., Zatelli M.C.,
RA   Uberti E.C.;
RT   "Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell
RT   lines.";
RL   J. Cell. Physiol. 212:293-297(2007).
RN   [14]
RP   FUNCTION, AND INTERACTION WITH PSMA7.
RX   PubMed=19362550; DOI=10.1016/j.yexcr.2009.03.021;
RA   Tandle A.T., Calvani M., Uranchimeg B., Zahavi D., Melillo G.,
RA   Libutti S.K.;
RT   "Endothelial monocyte activating polypeptide-II modulates endothelial cell
RT   responses by degrading hypoxia-inducible factor-1alpha through interaction
RT   with PSMA7, a component of the proteasome.";
RL   Exp. Cell Res. 315:1850-1859(2009).
RN   [15]
RP   SUBUNIT, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=19131329; DOI=10.1074/jbc.m809636200;
RA   Kaminska M., Havrylenko S., Decottignies P., Gillet S., Le Marechal P.,
RA   Negrutskii B., Mirande M.;
RT   "Dissection of the structural organization of the aminoacyl-tRNA synthetase
RT   complex.";
RL   J. Biol. Chem. 284:6053-6060(2009).
RN   [16]
RP   SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=19289464; DOI=10.1074/jbc.m900480200;
RA   Kaminska M., Havrylenko S., Decottignies P., Le Marechal P., Negrutskii B.,
RA   Mirande M.;
RT   "Dynamic Organization of Aminoacyl-tRNA Synthetase Complexes in the
RT   Cytoplasm of Human Cells.";
RL   J. Biol. Chem. 284:13746-13754(2009).
RN   [17]
RP   INVOLVEMENT IN HLD3.
RX   PubMed=21092922; DOI=10.1016/j.ajhg.2010.10.016;
RA   Feinstein M., Markus B., Noyman I., Shalev H., Flusser H., Shelef I.,
RA   Liani-Leibson K., Shorer Z., Cohen I., Khateeb S., Sivan S., Birk O.S.;
RT   "Pelizaeus-Merzbacher-like disease caused by AIMP1/p43 homozygous
RT   mutation.";
RL   Am. J. Hum. Genet. 87:820-828(2010).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [24]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-137, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [26]
RP   CLEAVAGE OF INITIATOR METHIONINE (ISOFORM 1), ACETYLATION AT ALA-2 (ISOFORM
RP   1), AND ACETYLATION AT MET-1 (ISOFORM 2).
RX   PubMed=37316325; DOI=10.26508/lsa.202301972;
RA   Bogaert A., Fijalkowska D., Staes A., Van de Steene T., Vuylsteke M.,
RA   Stadler C., Eyckerman S., Spirohn K., Hao T., Calderwood M.A., Gevaert K.;
RT   "N-terminal proteoforms may engage in different protein complexes.";
RL   Life. Sci Alliance 6:0-0(2023).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 147-312.
RX   PubMed=10852899; DOI=10.1074/jbc.c000216200;
RA   Kim Y., Shin J., Li R., Cheong C., Kim K., Kim S.;
RT   "A novel anti-tumor cytokine contains an RNA binding motif present in
RT   aminoacyl-tRNA synthetases.";
RL   J. Biol. Chem. 275:27062-27068(2000).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 148-312, AND FUNCTION.
RX   PubMed=11157763; DOI=10.1093/emboj/20.3.570;
RA   Renault L., Kerjan P., Pasqualato S., Menetrey J., Robinson J.-C.,
RA   Kawaguchi S., Vassylyev D.G., Yokoyama S., Mirande M., Cherfils J.;
RT   "Structure of the EMAPII domain of human aminoacyl-tRNA synthetase complex
RT   reveals evolutionary dimer mimicry.";
RL   EMBO J. 20:570-578(2001).
RN   [29] {ECO:0007744|PDB:4R3Z}
RP   X-RAY CRYSTALLOGRAPHY (4.03 ANGSTROMS) IN COMPLEX WITH QARS1 AND RARS1.
RX   PubMed=25288775; DOI=10.1073/pnas.1408836111;
RA   Fu Y., Kim Y., Jin K.S., Kim H.S., Kim J.H., Wang D., Park M., Jo C.H.,
RA   Kwon N.H., Kim D., Kim M.H., Jeon Y.H., Hwang K.Y., Kim S., Cho Y.;
RT   "Structure of the ArgRS-GlnRS-AIMP1 complex and its implications for
RT   mammalian translation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:15084-15089(2014).
CC   -!- FUNCTION: Non-catalytic component of the multisynthase complex.
CC       Stimulates the catalytic activity of cytoplasmic arginyl-tRNA synthase
CC       (PubMed:10358004). Binds tRNA. Possesses inflammatory cytokine activity
CC       (PubMed:11306575). Negatively regulates TGF-beta signaling through
CC       stabilization of SMURF2 by binding to SMURF2 and inhibiting its SMAD7-
CC       mediated degradation (By similarity). Involved in glucose homeostasis
CC       through induction of glucagon secretion at low glucose levels (By
CC       similarity). Promotes dermal fibroblast proliferation and wound repair
CC       (PubMed:16472771). Regulates KDELR1-mediated retention of HSP90B1/gp96
CC       in the endoplasmic reticulum (By similarity). Plays a role in
CC       angiogenesis by inducing endothelial cell migration at low
CC       concentrations and endothelian cell apoptosis at high concentrations
CC       (PubMed:12237313). Induces maturation of dendritic cells and monocyte
CC       cell adhesion (PubMed:11818442). Modulates endothelial cell responses
CC       by degrading HIF-1A through interaction with PSMA7 (PubMed:19362550).
CC       {ECO:0000250|UniProtKB:P31230, ECO:0000269|PubMed:10358004,
CC       ECO:0000269|PubMed:11157763, ECO:0000269|PubMed:11306575,
CC       ECO:0000269|PubMed:11818442, ECO:0000269|PubMed:12237313,
CC       ECO:0000269|PubMed:19362550}.
CC   -!- SUBUNIT: Homodimer. Part of the multisynthetase complex (MSC), a
CC       multisubunit complex that groups tRNA ligases for Arg (RARS1), Asp
CC       (DARS1), Gln (QARS1), Ile (IARS1), Leu (LARS1), Lys (KARS1), Met
CC       (MARS1) the bifunctional ligase for Glu and Pro (EPRS1) and the
CC       auxiliary subunits AIMP1/p43, AIMP2/p38 and EEF1E1/p18
CC       (PubMed:19131329, PubMed:19289464, PubMed:24312579). Interacts (via N-
CC       terminus) with RARS1 (via N-terminus) (PubMed:10358004,
CC       PubMed:17443684). Part of a complex composed of RARS1, QARS1 and AIMP1
CC       (PubMed:25288775). Interacts (via C-terminus) with SMURF2. Interacts
CC       (via N-terminus) with HSP90B1/gp96 (via C-terminus) (By similarity).
CC       Interacts with PSMA7 (PubMed:19362550). Interacts with TARS3
CC       (PubMed:24312579). {ECO:0000250|UniProtKB:P31230,
CC       ECO:0000269|PubMed:10358004, ECO:0000269|PubMed:11306575,
CC       ECO:0000269|PubMed:17443684, ECO:0000269|PubMed:19131329,
CC       ECO:0000269|PubMed:19289464, ECO:0000269|PubMed:19362550,
CC       ECO:0000269|PubMed:24312579, ECO:0000269|PubMed:25288775}.
CC   -!- INTERACTION:
CC       Q12904; Q13155: AIMP2; NbExp=5; IntAct=EBI-1045802, EBI-745226;
CC       Q12904; Q99598: TSNAX; NbExp=3; IntAct=EBI-1045802, EBI-21353855;
CC       Q12904; PRO_0000038593 [P04591]: gag; Xeno; NbExp=3; IntAct=EBI-1045802, EBI-6179719;
CC       Q12904-2; Q13155: AIMP2; NbExp=5; IntAct=EBI-12412735, EBI-745226;
CC       Q12904-2; Q86YM7: HOMER1; NbExp=3; IntAct=EBI-12412735, EBI-746815;
CC       Q12904-2; Q96CV9: OPTN; NbExp=6; IntAct=EBI-12412735, EBI-748974;
CC       Q12904-2; P54136: RARS1; NbExp=3; IntAct=EBI-12412735, EBI-355482;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:14500886}. Cytoplasm,
CC       cytosol {ECO:0000269|PubMed:19289464}. Secreted
CC       {ECO:0000269|PubMed:10850427}. Endoplasmic reticulum
CC       {ECO:0000250|UniProtKB:P31230}. Golgi apparatus
CC       {ECO:0000250|UniProtKB:P31230}. Note=Enriched in secretory vesicles of
CC       pancreatic alpha cells and secreted from the pancreas in response to
CC       low glucose levels (By similarity). Secreted in response to hypoxia
CC       (PubMed:10850427). Also secreted in response to both apoptotic and
CC       necrotic cell death. {ECO:0000250|UniProtKB:P31230,
CC       ECO:0000269|PubMed:10850427}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q12904-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q12904-2; Sequence=VSP_042197;
CC   -!- PTM: Cleaved by caspase-7 in response to apoptosis to produce EMAP-II.
CC       {ECO:0000269|PubMed:10850427, ECO:0000269|PubMed:11306575}.
CC   -!- DISEASE: Leukodystrophy, hypomyelinating, 3 (HLD3) [MIM:260600]: A
CC       severe autosomal recessive hypomyelinating leukodystrophy characterized
CC       by early infantile onset of global developmental delay, lack of
CC       development, lack of speech acquisition, and peripheral spasticity
CC       associated with decreased myelination in the central nervous system.
CC       {ECO:0000269|PubMed:21092922}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U10117; AAA62202.1; -; mRNA.
DR   EMBL; CR542281; CAG47076.1; -; mRNA.
DR   EMBL; AK095951; BAG53174.1; -; mRNA.
DR   EMBL; AK303965; BAG64889.1; -; mRNA.
DR   EMBL; BC014051; AAH14051.1; -; mRNA.
DR   CCDS; CCDS3674.1; -. [Q12904-1]
DR   PIR; B55053; B55053.
DR   RefSeq; NP_001135887.1; NM_001142415.2. [Q12904-1]
DR   RefSeq; NP_001135888.2; NM_001142416.2. [Q12904-1]
DR   RefSeq; NP_004748.2; NM_004757.3. [Q12904-1]
DR   RefSeq; XP_016864324.1; XM_017008835.3. [Q12904-1]
DR   RefSeq; XP_016864325.1; XM_017008836.1.
DR   RefSeq; XP_047272366.1; XM_047416410.1. [Q12904-1]
DR   RefSeq; XP_054207221.1; XM_054351246.1. [Q12904-1]
DR   PDB; 1E7Z; X-ray; 2.05 A; A=148-312.
DR   PDB; 1EUJ; X-ray; 1.80 A; A/B=147-312.
DR   PDB; 1FL0; X-ray; 1.50 A; A=150-312.
DR   PDB; 4R3Z; X-ray; 4.03 A; A=1-312.
DR   PDB; 8J9S; X-ray; 3.01 A; A/B=1-79.
DR   PDB; 8ONG; Other; -; A=146-312.
DR   PDBsum; 1E7Z; -.
DR   PDBsum; 1EUJ; -.
DR   PDBsum; 1FL0; -.
DR   PDBsum; 4R3Z; -.
DR   PDBsum; 8J9S; -.
DR   PDBsum; 8ONG; -.
DR   AlphaFoldDB; Q12904; -.
DR   BMRB; Q12904; -.
DR   SMR; Q12904; -.
DR   BioGRID; 114679; 267.
DR   ComplexPortal; CPX-2469; Multiaminoacyl-tRNA synthetase complex.
DR   CORUM; Q12904; -.
DR   FunCoup; Q12904; 1600.
DR   IntAct; Q12904; 71.
DR   MINT; Q12904; -.
DR   STRING; 9606.ENSP00000378191; -.
DR   ChEMBL; CHEMBL4295810; -.
DR   MoonProt; Q12904; -.
DR   GlyGen; Q12904; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q12904; -.
DR   PhosphoSitePlus; Q12904; -.
DR   SwissPalm; Q12904; -.
DR   BioMuta; AIMP1; -.
DR   DMDM; 85700432; -.
DR   jPOST; Q12904; -.
DR   MassIVE; Q12904; -.
DR   PaxDb; 9606-ENSP00000378191; -.
DR   PeptideAtlas; Q12904; -.
DR   ProteomicsDB; 59011; -. [Q12904-1]
DR   ProteomicsDB; 59012; -. [Q12904-2]
DR   Pumba; Q12904; -.
DR   ABCD; Q12904; 1 sequenced antibody.
DR   Antibodypedia; 4317; 615 antibodies from 45 providers.
DR   DNASU; 9255; -.
DR   Ensembl; ENST00000358008.7; ENSP00000350699.3; ENSG00000164022.18. [Q12904-1]
DR   Ensembl; ENST00000671868.1; ENSP00000499850.1; ENSG00000164022.18. [Q12904-1]
DR   Ensembl; ENST00000671960.1; ENSP00000500025.1; ENSG00000164022.18. [Q12904-1]
DR   Ensembl; ENST00000672285.1; ENSP00000500668.1; ENSG00000164022.18. [Q12904-1]
DR   Ensembl; ENST00000672328.1; ENSP00000500159.1; ENSG00000164022.18. [Q12904-1]
DR   Ensembl; ENST00000672337.1; ENSP00000499921.1; ENSG00000164022.18. [Q12904-1]
DR   Ensembl; ENST00000672341.1; ENSP00000500620.1; ENSG00000164022.18. [Q12904-1]
DR   Ensembl; ENST00000672911.1; ENSP00000500170.1; ENSG00000164022.18. [Q12904-1]
DR   Ensembl; ENST00000673018.1; ENSP00000500732.1; ENSG00000164022.18. [Q12904-1]
DR   Ensembl; ENST00000673123.1; ENSP00000500794.1; ENSG00000164022.18. [Q12904-1]
DR   GeneID; 9255; -.
DR   KEGG; hsa:9255; -.
DR   MANE-Select; ENST00000672341.1; ENSP00000500620.1; NM_001142416.2; NP_001135888.2.
DR   UCSC; uc003hyg.4; human. [Q12904-1]
DR   AGR; HGNC:10648; -.
DR   CTD; 9255; -.
DR   DisGeNET; 9255; -.
DR   GeneCards; AIMP1; -.
DR   HGNC; HGNC:10648; AIMP1.
DR   HPA; ENSG00000164022; Low tissue specificity.
DR   MalaCards; AIMP1; -.
DR   MIM; 260600; phenotype.
DR   MIM; 603605; gene.
DR   OpenTargets; ENSG00000164022; -.
DR   Orphanet; 88616; Autosomal recessive non-syndromic intellectual disability.
DR   Orphanet; 280293; Pelizaeus-Merzbacher-like disease due to AIMP1 mutation.
DR   VEuPathDB; HostDB:ENSG00000164022; -.
DR   eggNOG; KOG2241; Eukaryota.
DR   GeneTree; ENSGT00940000154950; -.
DR   HOGENOM; CLU_009710_6_1_1; -.
DR   InParanoid; Q12904; -.
DR   OMA; QPDLCTN; -.
DR   OrthoDB; 197206at2759; -.
DR   PAN-GO; Q12904; 0 GO annotations based on evolutionary models.
DR   PhylomeDB; Q12904; -.
DR   PathwayCommons; Q12904; -.
DR   Reactome; R-HSA-2408522; Selenoamino acid metabolism.
DR   Reactome; R-HSA-379716; Cytosolic tRNA aminoacylation.
DR   Reactome; R-HSA-9856649; Transcriptional and post-translational regulation of MITF-M expression and activity.
DR   SignaLink; Q12904; -.
DR   SIGNOR; Q12904; -.
DR   BioGRID-ORCS; 9255; 14 hits in 1163 CRISPR screens.
DR   ChiTaRS; AIMP1; human.
DR   EvolutionaryTrace; Q12904; -.
DR   GeneWiki; SCYE1; -.
DR   GenomeRNAi; 9255; -.
DR   Pharos; Q12904; Tbio.
DR   PRO; PR:Q12904; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; Q12904; protein.
DR   Bgee; ENSG00000164022; Expressed in calcaneal tendon and 215 other cell types or tissues.
DR   ExpressionAtlas; Q12904; baseline and differential.
DR   GO; GO:0017101; C:aminoacyl-tRNA synthetase multienzyme complex; IDA:UniProtKB.
DR   GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0005615; C:extracellular space; ISS:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005125; F:cytokine activity; ISS:HGNC-UCL.
DR   GO; GO:0051020; F:GTPase binding; IPI:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:HGNC-UCL.
DR   GO; GO:0000049; F:tRNA binding; IDA:HGNC-UCL.
DR   GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0007267; P:cell-cell signaling; IDA:HGNC-UCL.
DR   GO; GO:0051607; P:defense response to virus; IEA:Ensembl.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0050900; P:leukocyte migration; IDA:HGNC-UCL.
DR   GO; GO:0001937; P:negative regulation of endothelial cell proliferation; IDA:HGNC-UCL.
DR   GO; GO:0070094; P:positive regulation of glucagon secretion; ISS:UniProtKB.
DR   GO; GO:0006412; P:translation; IEA:UniProtKB-KW.
DR   CDD; cd02799; tRNA_bind_EMAP-II_like; 1.
DR   FunFam; 2.40.50.140:FF:000047; tyrosine--tRNA ligase, cytoplasmic isoform X2; 1.
DR   Gene3D; 2.40.50.140; Nucleic acid-binding proteins; 1.
DR   InterPro; IPR012340; NA-bd_OB-fold.
DR   InterPro; IPR002547; tRNA-bd_dom.
DR   InterPro; IPR051270; Tyrosine-tRNA_ligase_regulator.
DR   PANTHER; PTHR11586:SF33; AMINOACYL TRNA SYNTHASE COMPLEX-INTERACTING MULTIFUNCTIONAL PROTEIN 1; 1.
DR   PANTHER; PTHR11586; TRNA-AMINOACYLATION COFACTOR ARC1 FAMILY MEMBER; 1.
DR   Pfam; PF01588; tRNA_bind; 1.
DR   SUPFAM; SSF50249; Nucleic acid-binding proteins; 1.
DR   PROSITE; PS50886; TRBD; 1.
DR   neXtProt; NX_Q12904; -.
DR   PharmGKB; PA35578; -.
DR   TreeFam; TF324775; -.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Angiogenesis; Apoptosis;
KW   Cytokine; Cytoplasm; Direct protein sequencing; Endoplasmic reticulum;
KW   Golgi apparatus; Inflammatory response; Isopeptide bond; Leukodystrophy;
KW   Nucleus; Phosphoprotein; Protein biosynthesis; Proteomics identification;
KW   Reference proteome; RNA-binding; Secreted; tRNA-binding; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:24312579,
FT                   ECO:0000269|PubMed:37316325, ECO:0007744|PubMed:22223895,
FT                   ECO:0007744|PubMed:22814378"
FT   CHAIN           2..312
FT                   /note="Aminoacyl tRNA synthase complex-interacting
FT                   multifunctional protein 1"
FT                   /id="PRO_0000223394"
FT   CHAIN           147..312
FT                   /note="Endothelial monocyte-activating polypeptide 2"
FT                   /id="PRO_0000019242"
FT   DOMAIN          151..252
FT                   /note="tRNA-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00209"
FT   REGION          6..46
FT                   /note="Required for fibroblast proliferation"
FT   REGION          54..194
FT                   /note="Interaction with HSP90B1"
FT                   /evidence="ECO:0000250"
FT   REGION          101..114
FT                   /note="Required for endothelial cell death"
FT   REGION          107..147
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          114..192
FT                   /note="Required for endothelial cell migration"
FT   COMPBIAS        111..138
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|PubMed:24312579,
FT                   ECO:0000269|PubMed:37316325, ECO:0007744|PubMed:22223895,
FT                   ECO:0007744|PubMed:22814378"
FT   MOD_RES         140
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         269
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P31230"
FT   CROSSLNK        137
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0007744|PubMed:25114211"
FT   VAR_SEQ         1
FT                   /note="M -> MLPAVAVSEPVVLRFMIFCRLLAKM (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000305|PubMed:24312579"
FT                   /id="VSP_042197"
FT   VARIANT         79
FT                   /note="P -> A (in dbSNP:rs1134648)"
FT                   /evidence="ECO:0000269|PubMed:7929199"
FT                   /id="VAR_025212"
FT   VARIANT         104
FT                   /note="T -> A (in dbSNP:rs113844295)"
FT                   /id="VAR_029156"
FT   VARIANT         117
FT                   /note="T -> A (in dbSNP:rs2230255)"
FT                   /id="VAR_050124"
FT   CONFLICT        138
FT                   /note="Q -> R (in Ref. 3; BAG64889)"
FT                   /evidence="ECO:0000305"
FT   HELIX           6..72
FT                   /evidence="ECO:0007829|PDB:8J9S"
FT   HELIX           152..154
FT                   /evidence="ECO:0007829|PDB:1FL0"
FT   STRAND          157..168
FT                   /evidence="ECO:0007829|PDB:1FL0"
FT   STRAND          171..180
FT                   /evidence="ECO:0007829|PDB:1FL0"
FT   STRAND          182..185
FT                   /evidence="ECO:0007829|PDB:1FL0"
FT   STRAND          187..191
FT                   /evidence="ECO:0007829|PDB:1FL0"
FT   TURN            194..196
FT                   /evidence="ECO:0007829|PDB:1FL0"
FT   HELIX           199..202
FT                   /evidence="ECO:0007829|PDB:1FL0"
FT   STRAND          205..210
FT                   /evidence="ECO:0007829|PDB:1FL0"
FT   STRAND          216..220
FT                   /evidence="ECO:0007829|PDB:1FL0"
FT   STRAND          221..223
FT                   /evidence="ECO:0007829|PDB:1EUJ"
FT   STRAND          229..232
FT                   /evidence="ECO:0007829|PDB:1FL0"
FT   STRAND          235..238
FT                   /evidence="ECO:0007829|PDB:1FL0"
FT   STRAND          262..264
FT                   /evidence="ECO:0007829|PDB:1EUJ"
FT   TURN            266..268
FT                   /evidence="ECO:0007829|PDB:1FL0"
FT   HELIX           271..274
FT                   /evidence="ECO:0007829|PDB:1FL0"
FT   HELIX           275..277
FT                   /evidence="ECO:0007829|PDB:1FL0"
FT   STRAND          278..280
FT                   /evidence="ECO:0007829|PDB:1FL0"
FT   STRAND          284..288
FT                   /evidence="ECO:0007829|PDB:1FL0"
FT   TURN            296..298
FT                   /evidence="ECO:0007829|PDB:1FL0"
FT   STRAND          310..312
FT                   /evidence="ECO:0007829|PDB:1E7Z"
FT   MOD_RES         Q12904-2:1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000269|PubMed:37316325"
SQ   SEQUENCE   312 AA;  34353 MW;  5F0BF73E58810C60 CRC64;
     MANNDAVLKR LEQKGAEADQ IIEYLKQQVS LLKEKAILQA TLREEKKLRV ENAKLKKEIE
     ELKQELIQAE IQNGVKQIPF PSGTPLHANS MVSENVIQST AVTTVSSGTK EQIKGGTGDE
     KKAKEKIEKK GEKKEKKQQS IAGSADSKPI DVSRLDLRIG CIITARKHPD ADSLYVEEVD
     VGEIAPRTVV SGLVNHVPLE QMQNRMVILL CNLKPAKMRG VLSQAMVMCA SSPEKIEILA
     PPNGSVPGDR ITFDAFPGEP DKELNPKKKI WEQIQPDLHT NDECVATYKG VPFEVKGKGV
     CRAQTMSNSG IK
//
